Summit Securities Group’s Bausch Health BHC Stock Holding History

Summit Securities Group’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,831	Closed	-$11.8K	–	1029
2025 Q3	$11.8K	Buy	+1,831	New	+$12.5K	﹤0.01%	860
2023 Q1	–	Sell	-4,246	Closed	-$27K	–	830
2022 Q4	$27K	Buy	+4,246	New	+$29.7K	﹤0.01%	839
2022 Q1	–	Sell	-20,000	Closed	-$489K	–	1102
2021 Q4	$552K	Buy	+20,000	New	+$535K	0.03%	344
2015 Q4	–	Sell	-2,095	Closed	-$374K	–	292
2015 Q3	$374K	Buy	2,095 +1,877	+861%	+$438K	0.27%	52
2015 Q2	$48K	Buy	+218	New	+$48.3K	0.02%	215

Other funds holding BHC

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Summit Securities Group's BHC Position: Q4 2025 in Review

Summit Securities Group sold out of Bausch Health (BHC) in Q4 2025, closing a stake of 1,831 shares — an estimated $11.8K sold.

Summit Securities Group first reported a position in BHC in Q2 2015 and held it in 5 quarters. The position peaked at $552K in Q4 2021. 236 funds tracked by Wall St. Rank hold BHC as of Q4 2025.

Summit Securities Group reported no remaining Bausch Health position as of Q4 2025 after selling out during the quarter.
Summit Securities Group sold 1,831 Bausch Health shares in Q4 2025, an estimated $11.8K.
Summit Securities Group first reported a position in Bausch Health in Q2 2015 and held it in 5 quarters.
Summit Securities Group's Bausch Health position peaked at $552K in Q4 2021.
236 funds tracked by Wall St. Rank held Bausch Health as of Q4 2025.

Based on Summit Securities Group's 13F filing for Q4 2025, filed 17 Feb 2026.